Screener
Lucid Diagnostics LUCD Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $1.47M+26.7% | $1.26M+51.7% | $1.5M+25.6% | $1.21M+3.3% | $1.16M+19.2% | ||
| $1.45M-7.5% | $1.63M+4.8% | —— | —— | $1.56M-11.9% | ||
| $1.19M-5.0% | $1.21M-15.5% | $1.72M+18.6% | $1.27M-23.6% | $1.26M-8.5% | ||
| $5.78M+44.1% | $5M+22.9% | $5.34M+33.4% | $4.29M+5.8% | $4.01M-4.8% | ||
| $5.76M+2.5% | $5.43M-11.8% | $6.48M+10.6% | $5.61M+4.7% | $5.62M+15.4% | ||
| $14.28M+13.8% | $13.37M+0.4% | —— | —— | $12.55M-0.4% | ||
| -$12.8M-12.4% | -$12.11M+3.0% | -$14.01M-13.2% | -$11.76M-0.6% | -$11.38M-1.7% | ||
| -868.5%+110pp | -964.5%+544pp | -931.6%+102pp | -971%+26.8pp | -978.8%+168pp | ||
| $4K-33.3% | $6K-33.3% | $6K-14.3% | $2K+100% | $6K0.0% | ||
| $1.11M-84.0% | -$1.8M+87.6% | -$2.26M-370% | $1.36M+301% | $6.95M+3,614% | ||
| -$11.69M-163% | -$13.91M+48.3% | -$16.27M-40.9% | -$10.4M+16.0% | -$4.44M+59.7% | ||
| $0— | $0— | —— | —— | $0— | ||
| -$11.69M-163% | -$13.91M+48.3% | -$16.27M-40.9% | -$10.4M+16.0% | -$4.44M+59.7% | ||
| -792.9%-411pp | -1,107.4%+2,142pp | -1,081.5%-117pp | -858.5%+197pp | -381.7%+746pp | ||
| -$12.58M-12.7% | -$11.89M+3.0% | -$13.8M-13.6% | -$11.54M-0.5% | -$11.16M-1.8% | ||
| -853.3%+107pp | -946.8%+535pp | -917.7%+97.6pp | -952.8%+26.6pp | -959.8%+163pp | ||
| -$12.8M-12.4% | -$12.11M+3.0% | -$14.01M-13.2% | -$11.76M-0.6% | -$11.38M-1.7% |
FAQ
- What is Lucid Diagnostics's revenue?
- Lucid Diagnostics (LUCD) generated $5.4M in revenue over the trailing twelve months, up 24.9% year over year.
- Is Lucid Diagnostics profitable?
- Lucid Diagnostics is not currently profitable: it reported a net loss of $52.3M over the trailing twelve months, a -959.8% net margin.
- What are Lucid Diagnostics's profit margins?
- Gross margin is -57.3% and operating margin is -930.9%, with a -959.8% net margin.
- Where does Lucid Diagnostics's income statement data come from?
- Every line is extracted from Lucid Diagnostics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
